137 related articles for article (PubMed ID: 33016685)
1. Can the Total Thrombus-formation Analysis System (T‑TAS) better predict coagulation disorders than conventional laboratory measurements in patients with polycystic ovary syndrome?
Ożegowska K; Mantaj U; Rojewska P; Osiński M; Pawelczyk L; Kędzia M
Pol Arch Intern Med; 2020 Dec; 130(12):1114-1117. PubMed ID: 33016685
[No Abstract] [Full Text] [Related]
2. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index.
Rodrigues CE; Ferreira Lde L; Jansen K; Lopez MR; Drews Júnior CR; Souza LD
Rev Bras Ginecol Obstet; 2012 Oct; 34(10):442-6. PubMed ID: 23288220
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index.
Moin ASM; Sathyapalan T; Butler AE; Atkin SL
J Transl Med; 2021 Jun; 19(1):239. PubMed ID: 34078378
[No Abstract] [Full Text] [Related]
5. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.
Glueck CJ; Iyengar S; Goldenberg N; Smith LS; Wang P
J Lab Clin Med; 2003 Jul; 142(1):35-45. PubMed ID: 12878984
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Srikanthan P; Korenman S; Davis S
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
[TBL] [Abstract][Full Text] [Related]
7. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome.
Usta A; Avci E; Bulbul CB; Kadi H; Adali E
Reprod Biol Endocrinol; 2018 Apr; 16(1):34. PubMed ID: 29631598
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of macroprolactinemia in 259 women under investigation for polycystic ovary syndrome.
Hayashida SA; Marcondes JA; Soares JM; Rocha MP; Barcellos CR; Kobayashi NK; Baracat EC; Maciel GA
Clin Endocrinol (Oxf); 2014 Apr; 80(4):616-8. PubMed ID: 23758202
[No Abstract] [Full Text] [Related]
9. Comment on the grouping of patients with polycystic ovary syndrome based on body mass index.
Wei J
Hum Reprod; 2021 Dec; 37(1):193. PubMed ID: 34791247
[No Abstract] [Full Text] [Related]
10. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
[TBL] [Abstract][Full Text] [Related]
11. Cord blood anti-Müllerian hormone levels are higher in female newborns from women with polycystic ovary syndrome (PCOS) when compared to non-PCOS controls, irrespective of body mass index; a prospective case-control study.
Baydemir ŞK; Sukur YE; Ersan N; Dogan O; Atabekoglu CS
JBRA Assist Reprod; 2023 Sep; 27(3):422-427. PubMed ID: 37417851
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic evaluation of diastolic functions in patients with polycystic ovary syndrome: A comperative study of diastolic functions in sub-phenotypes of polycystic ovary syndrome.
Yildirim E; Karabulut O; Yuksel UC; Celik M; Bugan B; Gokoglan Y; Ulubay M; Gungor M; Koklu M
Cardiol J; 2017; 24(4):364-373. PubMed ID: 28353313
[TBL] [Abstract][Full Text] [Related]
13. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
Carmina E; Fruzzetti F; Lobo RA
Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
[TBL] [Abstract][Full Text] [Related]
14. [Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].
Melo AS; Macedo CS; Romano LG; Ferriani RA; Navarro PA
Rev Bras Ginecol Obstet; 2012 Jan; 34(1):4-10. PubMed ID: 22358341
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa.
Pinhas-Hamiel O; Pilpel N; Carel C; Singer S
Fertil Steril; 2006 Jun; 85(6):1849-51. PubMed ID: 16650415
[TBL] [Abstract][Full Text] [Related]
16. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women.
Dou P; Ju H; Shang J; Li X; Xue Q; Xu Y; Guo X
J Ovarian Res; 2016 Aug; 9(1):51. PubMed ID: 27557677
[TBL] [Abstract][Full Text] [Related]
17. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
[TBL] [Abstract][Full Text] [Related]
18. Re: Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Verit FF
Fertil Steril; 2010 Apr; 93(6):e27; author reply e28. PubMed ID: 20171617
[No Abstract] [Full Text] [Related]
19. An unusual case report of polycystic ovary syndrome.
Muscogiuri G; Docimo A; Colao A
J Endocrinol Invest; 2022 Jul; 45(7):1459-1460. PubMed ID: 35384600
[No Abstract] [Full Text] [Related]
20. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
